Biological significance of CDKN2A-ARF inactivation of glioma and meningioma progression.
CDKN2A-ARF 失活对神经胶质瘤和脑膜瘤进展的生物学意义。
基本信息
- 批准号:15591546
- 负责人:
- 金额:$ 2.24万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2003
- 资助国家:日本
- 起止时间:2003 至 2004
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
It was shown that the p14 (alternating reading frame : ARF) gene was frequently deleted in the majority of p53 wild-type (WT) glioblastomas, suggesting that p14 (ARF) inactivation contributes to p53-WT glioma progression. p14 (ARF) protein binds to MDM2 and inhibits MDM2-mediated degradation of p53. To assess the biological significance of p14 (ARF) inactivation in glioma, we introduced an in vivo Doxycycline (DOX)-regulated inducible p14 (ARF) expression system to p14 (ARF)-negative cells. Human glioblastoma cell lines, U87MG (p14-deleted, p53-WT), U251MG (p14-deleted, p53-mutated) were used in this study. We established U87MG- or U251MG-derived clones with in vivo inducible p14 expression and injected subcutaneously into the bilateral flanks of nude mice in the presence of DOX. When the tumor volume reached to 60 mm^3, we divided mice into two groups; one is maintained with DOX (p14 expression -), and the other without DOX (p14 expression +). The size of tumors were examined and scored. Induction of p14 expression significantly suppressed the in vivo growth of U87MG cells. U251MG cells, however, grew regardless of p14 expression. These findings strongly indicated that exogenous p14 expression inhibits the proliferation of p53-WT glioma cells. Inactivation of p14 would play an important role in the enhancement of unregulated glioma growth in vivo.We found loss of p14 (ARF) expression in majority of anaplastic or atypical meningiomas. Meningiomas with the absence of p14 (ARF) expression exclusively showed homozygous deletion of not only the p14 (ARF) gene but also the CDKN2A gene. Both genes are located on chromosome 9p21. These results suggested that loss of p14 (ARF) - CDKN2A loci was associated with ARF/p53 and CDKN2A/RB pathway, leading to malignant transformation of meningioma cells.
结果表明,p14(交替阅读框:ARF)基因在大多数p53野生型(WT)胶质母细胞瘤中经常缺失,表明p14(ARF)失活有助于p53-WT胶质瘤的进展。p14(ARF)蛋白结合MDM 2并抑制MDM 2介导的p53降解。为了评估p14(ARF)失活在胶质瘤中的生物学意义,我们将体内多西环素(DOX)调节的诱导型p14(ARF)表达系统引入p14(ARF)阴性细胞。本研究使用人胶质母细胞瘤细胞系U87 MG(p14缺失,p53-WT)、U251 MG(p14缺失,p53突变)。我们建立了U87 MG或U251 MG衍生的克隆与体内诱导型p14的表达,并皮下注射到裸鼠的双侧胁下的DOX的存在。当肿瘤体积达到60 mm^3时,我们将小鼠分为两组;一组维持DOX(p14表达-),另一组不维持DOX(p14表达+)。检查肿瘤大小并进行评分。诱导p14表达可显著抑制U87 MG细胞的体内生长。然而,U251 MG细胞生长与p14表达无关。这些发现强烈地表明外源性p14表达抑制p53-WT胶质瘤细胞的增殖。p14的失活在增强胶质瘤的生长中起重要作用,我们发现在大多数间变性或非典型脑膜瘤中p14(ARF)表达缺失。p14(ARF)表达缺失的脑膜瘤不仅表现出p14(ARF)基因的纯合性缺失,而且表现出CDKN 2A基因的纯合性缺失。这两个基因都位于染色体9 p21上。提示p14(ARF)-CDKN 2A基因位点缺失与ARF/p53和CDKN 2A/RB通路有关,导致脑膜瘤细胞恶性转化。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ADACHI Jun-ichi其他文献
閉環エンインメタセシスと増炭反応を鍵反応として利用する芳香族化合物の合成
以闭环烯炔复分解和渗碳反应为关键反应合成芳香族化合物
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
YAGISHITA Akira;ADACHI Jun-ichi;YAMAZAKI Masakazu;西井 佳奈 - 通讯作者:
西井 佳奈
マクロサイクルの自己組織化による超分子ナノチューブの合成と光学的特性
大环自组装超分子纳米管的合成及其光学性质
- DOI:
- 发表时间:
2009 - 期刊:
- 影响因子:0
- 作者:
KAZAMA Misato;YAMAZAKI Masakazu;ADACHI Jun-ichi;(他2名);塚本健一 - 通讯作者:
塚本健一
安定シリレンからトリシラアレンへ
从稳定的亚硅基到三硅芳基
- DOI:
- 发表时间:
2010 - 期刊:
- 影响因子:0
- 作者:
H. Toyokawa;T. Hirono;S. Wu;M. Kawase;Y. Furukawa;T. Ohata;吉良満夫;原田潤;Hidenori Toyokawa;ADACHI Jun-ichi;吉良満夫 - 通讯作者:
吉良満夫
Interferences and scatterings of photoelectron partial waves in core-level photoionization : Photoelectron angular distributions in coincidence measurements of photoelectrons and photoions
核心级光电离中光电子部分波的干扰和散射:光电子和光电离子符合测量中的光电子角分布
- DOI:
- 发表时间:
2009 - 期刊:
- 影响因子:0
- 作者:
K. Tono;K. Fukazawa;M. Tada;N. Fukusihma and K. Tsukiyama;中川剛基;ADACHI Jun-ichi - 通讯作者:
ADACHI Jun-ichi
ADACHI Jun-ichi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ADACHI Jun-ichi', 18)}}的其他基金
Fundamental processes of low-kinetic-energy-photoelectron diffraction for gaseous molecules.
气体分子低动能光电子衍射的基本过程。
- 批准号:
22550025 - 财政年份:2010
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Core-level photoionization dynamics with vibronic resolution from fixed-in-space molecules
具有固定空间分子振动分辨率的核心级光电离动力学
- 批准号:
19550027 - 财政年份:2007
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Biological Significance of p16 gene inactivation on glioma progress
p16基因失活对神经胶质瘤进展的生物学意义
- 批准号:
12671380 - 财政年份:2000
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Retrospective prognostic analysis based on molecular information of malignant glioma and malignant meningioma treated with BNCT
基于BNCT治疗恶性胶质瘤和恶性脑膜瘤分子信息的回顾性预后分析
- 批准号:
23K19519 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Metabolomic Analysis of Primary Human Meningioma and Schwannoma following Radiation Therapy: A Novel Approach to Identify Targetable Radiosensitive Pathways
放射治疗后原发性人类脑膜瘤和神经鞘瘤的代谢组学分析:识别靶向放射敏感途径的新方法
- 批准号:
10536483 - 财政年份:2022
- 资助金额:
$ 2.24万 - 项目类别:
A stalled chromatin regulatory network that mediates the oncogenic activity of Meningioma-1
介导 Meningioma-1 致癌活性的停滞染色质调控网络
- 批准号:
10579293 - 财政年份:2022
- 资助金额:
$ 2.24万 - 项目类别:
A stalled chromatin regulatory network that mediates the oncogenic activity of Meningioma-1
介导 Meningioma-1 致癌活性的停滞染色质调控网络
- 批准号:
10445974 - 财政年份:2022
- 资助金额:
$ 2.24万 - 项目类别:
Understanding druggable drivers of meningioma tumorigenesis
了解脑膜瘤肿瘤发生的药物驱动因素
- 批准号:
10663243 - 财政年份:2021
- 资助金额:
$ 2.24万 - 项目类别:
Understanding druggable drivers of meningioma tumorigenesis
了解脑膜瘤肿瘤发生的药物驱动因素
- 批准号:
10456201 - 财政年份:2021
- 资助金额:
$ 2.24万 - 项目类别:
Understanding druggable drivers of meningioma tumorigenesis
了解脑膜瘤肿瘤发生的药物驱动因素
- 批准号:
10275399 - 财政年份:2021
- 资助金额:
$ 2.24万 - 项目类别:
Elucidation of the relationship between infiltration ability and ACTC1 and its molecular mechanism in malignant meningioma
阐明恶性脑膜瘤浸润能力与ACTC1的关系及其分子机制
- 批准号:
21K09190 - 财政年份:2021
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of novel oligonucleotide therapy for malignant meningioma using inactivated viral particle
使用灭活病毒颗粒开发新型寡核苷酸疗法治疗恶性脑膜瘤
- 批准号:
21K09170 - 财政年份:2021
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Developement of TERT-targeting novel therapy of malignant meningioma
TERT靶向恶性脑膜瘤新疗法的开发
- 批准号:
20K09401 - 财政年份:2020
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)